PlainRecalls
FDA Drug Low Class III Terminated

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

Reported: December 13, 2023 Initiated: November 9, 2023 #D-0140-2024

Product Description

LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1

Reason for Recall

Product Mix-up: Incorrect Product Formulation

Details

Units Affected
190 syringes
Distribution
USA Nationwide
Location
Irving, TX

Frequently Asked Questions

What product was recalled?
LET Gel (Lidocaine HCL/Epinephrine Bitartrate/Tetracaine HCL 4%/0.18%/0.5% Topical Gel), Single-use Topical Syringe, 3mL syringe, 10/pack, Rx only, Carie Boyd Pharmaceuticals, 8400 Esters Blvd, Ste# 190, Irving, TX 75063, NDC73271-1003-1. Recalled by Right Value Drug Stores, LLC dba Carie Boyd's Prescription Shop. Units affected: 190 syringes.
Why was this product recalled?
Product Mix-up: Incorrect Product Formulation
Which agency issued this recall?
This recall was issued by the FDA Drug on December 13, 2023. Severity: Low. Recall number: D-0140-2024.